SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (194)11/13/2000 9:55:20 AM
From: scaram(o)uche  Read Replies (2) of 724
 
Novo Nordisk Concludes Private Placement Into ZymoGenetics

BAGSVAERD, Denmark, Nov. 13 /PRNewswire/ -- Novo Nordisk A/S (NYSE: NVO)
has on Friday, 10 November concluded the transaction it announced on
October 23 re a USD 150 million private placement into ZymoGenetics Inc from
an international investor consortium led by E M Warburg, Pincus & Co, LLC.

Novo Nordisk A/S is the world leader in insulin and diabetes care and also
manufactures and markets a variety of other pharmaceutical products.
Furthermore, the company is the world's largest producer of enzymes for
industrial use. Headquartered in Denmark, Novo Nordisk employs approximately
16,200 people in 68 countries and markets its products in 179 countries. Its
B shares are listed on the stock exchanges in Copenhagen and London. Its ADSs
are listed on the New York Stock Exchange under the symbol "NVO." A demerger
of Novo Nordisk with the intention to spin off the Enzyme Business into a
separately listed company is expected to take place following an extraordinary
general meeting in mid-November. For further company information, visit Novo
Nordisk on the World Wide Web at novo.dk

SOURCE Novo Nordisk A/S
Web Site: novo.dk
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News